[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples